How can clinical research help our understanding of trastuzumab-related cardiotoxicity?
Main Authors: | Tomás G. Lyons, Patrick G. Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-08-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396415300748 |
Similar Items
-
Trastuzumab Related Cardiotoxicity in Taiwanese Breast Cancer Women
by: Hsu-ChihChien, et al.
Published: (2016) -
Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity
by: Darryl P. Leong, MBBS, MPH, MBiostat, PhD, et al.
Published: (2019-09-01) -
A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
by: Sylvana Hidalgo, et al.
Published: (2013-01-01) -
Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution
by: Hamed Rasha Hamdy, et al.
Published: (2016-06-01) -
The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)